title: Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis.
abstract: We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.
authors.affiliation: Department of Paediatrics, University Clinic of Navarra, Faculty of Medicine, Pamplona, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Azcona
authors.forename: V
authors.initials: V
authors.lastname: Alzina
authors.forename: P
authors.initials: P
authors.lastname: Barona
authors.forename: L
authors.initials: L
authors.lastname: Sierrasesúmaga
authors.forename: I
authors.initials: I
authors.lastname: Villa-Elízaga
mesh_terms: D016026:Bone Marrow Transplantation; D017809:Fatal Outcome; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D016511:Severe Combined Immunodeficiency / Q000188:drug therapy* / Q000628:therapy
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor